These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cladribine (2-chloro-2'-deoxyadenosine): new perspectives in clinical immunosuppression. Górski A; Grieb P Arch Immunol Ther Exp (Warsz); 1994; 42(1):11-2. PubMed ID: 7503626 [TBL] [Abstract][Full Text] [Related]
3. A novel series of low molecular weight immunosuppressive agents. Ocain TD; Bastos CM; Gordon KA; Granstein RD; Jenson JC; Jones B; McAuliffe DJ; Newcomb JR Transplant Proc; 1996 Dec; 28(6):3032-4. PubMed ID: 8962176 [No Abstract] [Full Text] [Related]
4. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. Wolos JA; Frondorf KA; Babcock GF; Stripp SA; Bowlin TL Cell Immunol; 1993 Jul; 149(2):402-8. PubMed ID: 8330316 [TBL] [Abstract][Full Text] [Related]
5. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]
6. Discovery, mechanism and expected clinical significance of selective cytotoxicity of 2-chloro-2'-deoxyadenosine (2-CdA). Grieb P Arch Immunol Ther Exp (Warsz); 1994; 42(1):1-5. PubMed ID: 7503624 [TBL] [Abstract][Full Text] [Related]
7. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. Nagata Y; Furugen R; Hiasa A; Ikeda H; Ohta N; Furukawa K; Nakamura H; Furukawa K; Kanematsu T; Shiku H J Immunol; 1997 Aug; 159(3):1336-43. PubMed ID: 9233630 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effect of stepronin (TS-5010680) in mice. de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255 [No Abstract] [Full Text] [Related]
9. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH. Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251 [TBL] [Abstract][Full Text] [Related]
10. Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro. Górski A; Grieb P; Korczak-Kowalska G; Wierzbicki P; Stepień-Sopniewska B; Mrowiec T Immunopharmacology; 1993; 26(3):197-202. PubMed ID: 7904595 [TBL] [Abstract][Full Text] [Related]
11. Physalins B, F and G, seco-steroids purified from Physalis angulata L., inhibit lymphocyte function and allogeneic transplant rejection. Soares MB; Brustolim D; Santos LA; Bellintani MC; Paiva FP; Ribeiro YM; Tomassini TC; Ribeiro Dos Santos R Int Immunopharmacol; 2006 Mar; 6(3):408-14. PubMed ID: 16428076 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. Xu X; Williams JW; Shen J; Gong H; Yin DP; Blinder L; Elder RT; Sankary H; Finnegan A; Chong AS J Immunol; 1998 Jan; 160(2):846-53. PubMed ID: 9551920 [TBL] [Abstract][Full Text] [Related]
13. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy. Nawrocki G; Grieb P; Górski A; Danielewicz R; Rowiński W Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374 [No Abstract] [Full Text] [Related]
14. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice. Hori J; Yamagami S; Obata H; Tsuru T; Isobe M Transplant Proc; 1996 Jun; 28(3):1990-1. PubMed ID: 8658970 [No Abstract] [Full Text] [Related]
15. Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study. Kryczka T; Kazimierczuk Z; Kozłowska M; Chrapusta SJ; Vilpo L; Vilpo J; Stachnik K; Janisz M; Grieb P Anticancer Drugs; 2007 Mar; 18(3):301-10. PubMed ID: 17264763 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435 [TBL] [Abstract][Full Text] [Related]
17. Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment. Gotoh M; Fukuzaki T; Dono K; Wada H; Kanai T; Monden M; Yagita H; Okumura K; Mori T Transplant Proc; 1993 Feb; 25(1 Pt 2):973-4. PubMed ID: 8442286 [No Abstract] [Full Text] [Related]
18. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis. Rogers AM; Thilenius AR; Russell JH J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111 [TBL] [Abstract][Full Text] [Related]
19. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice. Hamano K; Morris PJ; Wood KJ Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483 [No Abstract] [Full Text] [Related]
20. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]